Precision gastroenterology represents a paradigm shift from generalized treatment strategies toward individualized, data-driven care. By integrating clinical phenotypes, genetic information, molecular biomarkers, microbiome profiles, and environmental factors, clinicians can better predict disease behavior and therapeutic response. Advances in multi-omics technologies, artificial intelligence, and digital health tools are enabling earlier diagnosis, personalized treatment selection, and improved disease monitoring. Precision approaches are increasingly applied in inflammatory bowel disease, gastrointestinal cancers, liver disease, and functional GI disorders. Biomarker-guided therapy, treat-to-target strategies, and risk-based surveillance are becoming central to modern practice. This topic explores the role of emerging technologies in enabling precision medicine, the challenges of data integration and implementation, and the future direction of personalized gastrointestinal care.
Title : Gut mucosal immunity and inflammatory bowel disease
Youcun Qian, University of Chinese Academy of Sciences, China
Title : Early and late evaluation of esophageal mucosectomy in surgical treatment of advanced esophageal achalasia
Jose Luis Braga De Aquino, Pontifical Catholic University of Campinas, Brazil
Title : The efficacy of fermented foods as an adjunct therapy in ulcerative colitis - a literature review
Jack D Doorly, Alfred Health, Australia
Title : Professional dining and health
Yaffa Machnes, Bar-Ilan University, Israel
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Invention City, United States
Title : Differentiating simple and aggressive phenotypes of metabolic dysfunction-associated steatotic liver disease utilizing bioelectrical impedance-derived metabolic age gap
Yury Marakhouski, Belarusian State Medical University, Belarus